• Now Enrolling: Massive Remote Study Tracking How the Brain Ages

    Clinical Research News | In the future, it may be possible for the physiological signals passively collected by a smartwatch to alert the wearer of a potential change in their cognitive state. Consumer electronics giant Samsung, for its part, has teamed up with the Neuroscape Center at the University of California San Francisco (UCSF) to explore the possibility of expanding the health- and fitness-tracking capabilities of its Galaxy Watch to assess functioning of the brain.

    Jul 23, 2026

  • Anthropic Announces Rare Disease Research Claude Grants

    Clinical Research News | Anthropic yesterday announced a focused call for applications for work on rare genetic diseases. Accepted applicants will receive up to $50,000 in Claude credits over six months, with the goal of building a community of researchers looking into how AI can reshape our understanding of rare disease.

    Jul 21, 2026

  • 3 Tips for a Lean and Efficient Clinical Data Management Function

    Clinical Research News | The landscape of clinical data management (CDM) is becoming increasingly complex. As a BCG report notes, sponsors’ expectations are rising. They are looking for greater consistency in speed and quality, better technology, and improved implementations.

    Jul 17, 2026

  • Coming Soon: One-time Treatment for Debilitating Genetic Condition

    Clinical Research News | Patients with hereditary angioedema have reason to be optimistic that regulatory approval of a one-time, in vivo CRISPR gene-editing therapy for the sudden and severe swelling attacks associated with the rare genetic condition could come as early as next year. Lonvoguran ziclumeran (lonvo-z), as it is known, has been under development by Intellia Therapeutics for the past six years.

    Jul 15, 2026

  • AI Eye Imaging Model Could Accelerate Clinical Trials and Drug Development

    Clinical Research News | An experimental artificial intelligence (AI) model called OCTCube-M could help improve patient selection, predict disease progression, and streamline clinical trials by extracting new insights from three-dimensional optical coherence tomography (OCT) eye scans.

    Jul 14, 2026

  • The Scope of Things: Scaling AI Agents In Clinical Trials

    Clinical Research News | Artificial intelligence agents are beginning to reshape clinical trial operations, but sponsors are still hesitating. Raj Indupuri, CEO of eClinical Solutions, joined the latest episode of The Scope of Things, hosted by Deborah Borfitz, to break down the three main obstacles hindering AI adoption: data readiness, governance and trust, and operating model change.

    Jul 9, 2026

  • Insilico Medicine Launches Phase III Trial for AI-Developed Drug

    Clinical Research News | Insilico Medicine is launching a phase III clinical program for rentosertib, its potentially first-in-class oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, age-related fibrotic lung disease with high unmet medical need. It is the next step in making AI-discovered drugs a reality for patients.

    Jul 8, 2026

  • Follow the Money: Liver Cell-Reprogramming Therapy, Full-Length Dystrophin Trial, Next-Gen Neuroplastogen

    Clinical Research News | cAMPfield is launching a global phase 2b trial for moderate-to-severe ulcerative colitis and a global phase 2 for Crohn’s disease; Gero intends to advance a portfolio of both disease-modifying and aging-slowing programs in parallel; ClearNote Health continues commercial clinical study execution and broader global access; and more.

    Jul 1, 2026

  • Restoring American Leadership in Clinical Trials, University of Texas MD Anderson Joins Global Consortium, Medable’s DDF Agent

    Clinical Research News | The Ellison Medical Institute enters an exclusive license with UniQuest; TrialAssure and Cancer Research UK’s Centre for Drug Development announce new partnership; EndoDNA launches BIOS, a clinical decision-support; and more.

    Jun 30, 2026

  • India Can Surpass China in Global Pharma. But Not Where Most People Think.

    Clinical Research News | India has long been called the pharmacy of the world. That reputation was earned through manufacturing scale, generics leadership, and the ability to supply medicines globally at extraordinary volume. But the next chapter for India’s pharmaceutical industry will be different. Recent industry discussion about India’s pharmaceutical ambitions has largely explored one question: Can India compete with China as a global pharmaceutical power?

    Jun 26, 2026

  • Novo Nordisk Clinical Trial Data Targeted in Data Attack

    Clinical Research News | In mid-June Novo Nordisk announced, “an IT security incident involving unauthorized access to a limited number of internal IT systems” that exposed personal information for clinical trial participants. Novo Nordisk listed the exposed data categories as Patient ID (random alphanumeric string) and information on trial participation; sex; year of birth; biomarkers; health/immunogenicity data; and lifestyle factors including smoking, alcohol use, and BMI.

    Jun 23, 2026

  • Moving from Active to Autonomous TMF with Agentic AI

    Clinical Research News | For years, TMF leaders advocated for active TMF, a model where the TMF is a "place to go to do your work" instead of a passive archive. The shift to active TMF made significant progress for life sciences, moving toward applications that deliver real-time trial execution and TMF management. With the introduction of agentic AI in clinical trials, TMF management is now evolving from active to autonomous.

    Jun 18, 2026

  • The Invisible Infrastructure: Bio-IT World Panel Warns of a Slow-Motion Crisis in Biomedical Data

    Clinical Research News | At last month's Bio-IT World Conference & Expo, Douaa Mugahid, PhD, Data Officer at the Hi-IMPAcTB Consortium at the Harvard School of Public Health moderated a panel of academics, investors, and consultants to take on the future of public data and software infrastructure. It is time to safeguard publicly funded data infrastructure, which underpins virtually all of modern biomedical research.

    Jun 17, 2026

  • A Simple Swab Could Change How Doctors Detect Endometrial Cancer

    Clinical Research News | For the roughly 1.3 to 2 million women who visit their doctor each year with abnormal postmenopausal bleeding, the diagnostic journey has long been an uncomfortable one. The standard workup typically involves an endometrial biopsy—an invasive, often painful procedure that, despite its widespread use, fails to yield a conclusive diagnosis in more than 30% of cases. Two veteran diagnostics executives think there's a better way, and they're betting nearly $45 million in venture funding on it.

    Jun 16, 2026

  • Urine Liquid Biopsy Shows Strong Promise for Guiding Bladder Cancer Treatment — Clinical Trials on the Horizon

    Clinical Research News | A novel urine-based liquid biopsy developed at Stanford University is showing remarkable accuracy in predicting bladder cancer recurrence and may soon reshape how clinical trials enroll and treat patients. The test, developed by urologic oncologist Joseph Liao, M.D., and colleagues, filters out age-related background mutations in urine to produce a cleaner, more reliable signal for detecting residual cancer after surgery and immunotherapy.

    Jun 11, 2026

  • The Scope of Things: Measuring Equity in Cancer Care

    Clinical Research News | In the latest episode of The Scope of Things, Eugene Manley, Jr., founder and CEO of the STEMM & Cancer Health Equity Foundation, explains how underrepresented populations, including Black, Hispanic, Indigenous, rural, low-income, immigrant, underinsured, and uninsured communities, are less likely to receive guideline-aligned biomarker testing and less likely to be asked about clinical trial participation at all.

    Jun 9, 2026

  • Regulatory Outlook in Diagnostics Innovative and Uncertain

    Clinical Research News | The diagnostics industry is at the intersection of enormous clinical development and technological change, enabling first-ever detection milestones heavily driven by artificial intelligence and multi-biomarker tests. But it has increasingly been coming into conflict with a decades-old regulatory system that didn’t anticipate these technological changes and a political environment that favors U.S. competition and innovation but is also interested in cutting the budget.

    Jun 4, 2026

  • A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

    Clinical Research News | VeriSIM Life is building the “full-stack predictive infrastructure” to help pharma companies foresee the challenges ahead in translating a molecule from laboratory discovery to a successful human therapy. The help comes in the form of a dynamic, “credit-score-like” assessment of the risk with inherent explainability and trust.

    Jun 3, 2026

  • Phesi Highlights Disconnect Between Protocols and Outcomes, Warns of AI Repetition

    Clinical Research News | An analysis released by Phesi suggests that the systematic use of historical protocol templates without using patient data and context to guide protocol design leads to flaws being scaled, rather than solved, by AI.

    Jun 2, 2026

  • Flatiron’s AI-Powered Platform, Verana Health Ovarian Cancer Database, Eir Partners Invests in QuartzBio

    Clinical Research News | uMotif launches its new Scientific Consulting Services; Veeva Systems announces Veeva Falcon; b.well Connected Health and myTomorrows announce a partnership; and more.

    May 29, 2026